RE:RE:Cancer drug shortages - heads upIn March, the FDA’s actions in preventing and responding to the shortages were probed in Congress as the House Committee on Energy and Commerce launched an investigation to uncover if the agency is “effectively using its existing authorities.”
In response to this Congressional probe, the FDA has issued their guidance on the "Accelerated Approval" process which is intended to approve and bring novel oncology drugs into the market at a much greater rate than ever before.